Research Overview: HGH (100 IU) Aquila Pharmaceuticals
HGH (100 IU) Aquila Pharmaceuticals is a recombinant human growth hormone preparation formulated specifically for in-vitro research applications. This high-potency research compound enables laboratory investigations into growth hormone signalling pathways, cellular regeneration mechanisms, and metabolic regulatory processes. Aquila Pharmaceuticals’ formulation provides researchers with a reliable tool for examining the complex biochemical interactions associated with somatotropin activity in controlled laboratory environments.
The 100 IU concentration offers research flexibility for various experimental protocols, allowing scientists to investigate dose-dependent responses across different cell culture systems. When conducting comparative studies with other research compounds available at Stroid UK Shop, researchers can evaluate synergistic effects and pathway interactions that may influence cellular growth and metabolic regulation.
Laboratory Research Applications
This research-grade HGH preparation serves multiple investigative purposes in laboratory settings. Researchers examine its effects on protein synthesis pathways, investigating how growth hormone signalling influences cellular anabolic processes and tissue repair mechanisms. Studies focus on IGF-1 pathway activation, exploring downstream signalling cascades that regulate cellular proliferation and differentiation.
Metabolic research applications include investigating lipolytic effects, examining how growth hormone influences lipid metabolism and energy utilisation in various cell types. Scientists studying regenerative medicine applications analyse the compound’s potential role in tissue engineering and cellular regeneration protocols. Comparative studies with growth hormones and related compounds from the SARMs and peptides categories provide comprehensive insights into growth-promoting mechanisms.
Product Specifications
| Manufacturer | Aquila Pharmaceuticals |
|---|---|
| Total Units | 100 IU |
| Form | Lyophilised powder |
| Purity | Verify with supplier |
| Storage | -20°C, protected from light |
| Research Use | In-vitro laboratory studies only |
| Molecular Weight | 22,124 Da (approximate) |
| CAS Number | Verify with supplier |
Research Compliance Statement
This HGH (100 IU) Aquila Pharmaceuticals preparation is intended exclusively for in-vitro research applications and laboratory studies. This product is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure compliance with local regulations governing growth hormone research compounds and maintain appropriate laboratory safety protocols during handling and storage.
